Discover more from The Kingston Report
Irrefutable Evidence: FDA Approved COMIRNATY is Available on Military Bases as of June 2022
August 3, 2022 email to Senators Ron Johnson and Rand Paul
From: Karen Kingston <firstname.lastname@example.org>
Date: August 3, 2022 at 2:57:47 PM PDT
To: Ron Johnson, Rand Paul
Cc: "Downey, Brian (HSGAC)" < >, Karen Kingston < >, Ann < >
Irrefutable Evidence: FDA Approved COMIRNATY is available on Military base as of June 2022
Dear Senators Rand Paul and Ron Johnson,
Attached is important information regarding the availability of FDA approved COMIRNATY on military bases.
Below is a video in which a soldier reads the FDA approval letters for the final COMIRNATY labeling and packaging and the FDA New Drug Codes (NDCs) issued on December 22, 2022 by the FDA WHILE HOLDING an FDA APPROVED VIAL of COMIRNATY with the approved packaging (including gray cap) and NDC code. (please go to the 5:12 mark)
COMIRNATY is available on at least one military base as of June 2022. It is impossible for FDA approved COMIRNATY to have been available to our military prior to Dec 22, 2022. This is important because COMIRNATY is legally and CLINICALLY a DIFFERENT PRODUCT than BNT162b. (see attached BLA letter noted in slides).
This fact is only an issue if Pfizer claims they did provide FDA approved product to the military in 2022, because the evidence shows that that did occur.
The attached slides contain links to all the relevant FDA, NIH and Pfizer documents and databases.
With respect – Karen Kingston
Thanks for reading Kingston Report! Subscribe for free to receive new posts and support my work.